Am. J. Respir. Crit. Care Med., Vol 155, No. 5, 05 1997, 1729-1734.
Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma
JM Sirvent, A Torres, M El-Ebiary, P Castro, J de Batlle and A Bonet
Departament de Medicina, Universitat de Barcelona, Spain.
In comatose patients admitted to an ICU, particularly those with head
injury, the incidence of early onset pneumonia is exceedingly high. We
performed an open, prospective, randomized, and controlled clinical trial
aiming at the reduction of the incidence of ventilator-associated pneumonia
in head-injured patients and patients with stroke requiring mechanical
ventilation. One hundred patients were included because of head injury or
coma caused by medical stroke and with Glasgow coma scores < or = 12 and
mechanical ventilation > 72 h. Patients eligible for the study (n = 50)
received cefuroxime intravenously (two 1,500-mg doses 12 h apart after
intubation) (the cefuroxime group) and 50 patients not receiving cefuroxime
formed the control group. In the former group patients did not receive any
other antibiotics before the end-point determination, whereas in the
latter, 17 patients received prophylactic antibiotics as prescribed by the
attending physician. The global incidence of microbiologically confirmed
pneumonia was 37% (n = 37); 12 (24%) belonged to the cefuroxime group, and
25 (50%) belonged to the control group (p = 0.007). Early-onset pneumonia
accounted for 70% of all the pneumonia episodes (n = 26), eight (67%)
belonging to the cefuroxime group, and 18 (72%) belonging to the control
group (p = 0.02). In the control group, four of 17 (23%) patients receiving
prior antibiotics developed pneumonia, whereas 21 of 33 (64%) patients who
did not receive antibiotics developed pneumonia (p = 0.016). The
multivariate analysis revealed that the duration of mechanical ventilation
(per each day) was an independent risk factor significantly associated to
the development of pneumonia. Furthermore, the use of cefuroxime and/or
prior antibiotics in the control group, before the pneumonia episode, had a
protective effect against its development. No differences were found with
regard to mortality and morbidity when comparing the study population with
the control group. Nevertheless, when comparing patients with pneumonia
(from both study and control groups) with those without it, there was a
decrease in total hospital stay (35 +/- 13 versus 25 +/- 14 d, p = 0.048)
and ICU stay (20 +/- 11 versus 11 +/- 7 d, p = 0.001). The study
demonstrated that the administration of two single high doses 1,500 mg each
of cefuroxime after the intubation of patients comatose because of head
injury or medical stroke is an effective prophylactic strategy to decrease
the incidence of ventilator-associated pneumonia.
This article has been cited by other articles:

|
 |

|
 |
 
A. Pobo, T. Lisboa, A. Rodriguez, R. Sole, M. Magret, S. Trefler, F. Gomez, J. Rello, and for the RASPALL Study Investigators
A Randomized Trial of Dental Brushing for Preventing Ventilator-Associated Pneumonia
Chest,
August 1, 2009;
136(2):
433 - 439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Niederman
Severe Pneumonia
ACCP Crit Care Med Brd Rev,
January 1, 2009;
20(0):
485 - 506.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Masterton, A. Galloway, G. French, M. Street, J. Armstrong, E. Brown, J. Cleverley, P. Dilworth, C. Fry, A. D. Gascoigne, et al.
Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy
J. Antimicrob. Chemother.,
July 1, 2008;
62(1):
5 - 34.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Lorente, S. Blot, and J. Rello
Evidence on measures for the prevention of ventilator-associated pneumonia
Eur. Respir. J.,
December 1, 2007;
30(6):
1193 - 1207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nseir, C. Di Pompeo, E. Jozefowicz, B. Cavestri, H. Brisson, M. Nyunga, S. Soubrier, and A. Durocher
Relationship between tracheotomy and ventilator-associated pneumonia: a case control study
Eur. Respir. J.,
August 1, 2007;
30(2):
314 - 320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K Thorburn, S Harigopal, V Reddy, N Taylor, and H K F van Saene
High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis
Thorax,
July 1, 2006;
61(7):
611 - 615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia
Am. J. Respir. Crit. Care Med.,
February 15, 2005;
171(4):
388 - 416.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Parker and D. K. Heyland
Aspiration and the Risk of Ventilator-Associated Pneumonia
Nutr Clin Pract,
December 1, 2004;
19(6):
597 - 609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rello and E. Diaz
Ventilator-Associated Pneumonia, Percutaneous Tracheostomy, and Antimicrobial Prophylaxis
Chest,
October 1, 2004;
126(4):
1382 - 1383.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. R. Collard, S. Saint, and M. A. Matthay
Prevention of Ventilator-Associated Pneumonia: An Evidence-Based Systematic Review
Ann Intern Med,
March 18, 2003;
138(6):
494 - 501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. A. Krueger, F.-P. Lenhart, G. Neeser, G. Ruckdeschel, H. Schreckhase, H.-J. Eissner, H. Forst, J. Eckart, K. Peter, and K. E. Unertl
Influence of Combined Intravenous and Topical Antibiotic Prophylaxis on the Incidence of Infections, Organ Dysfunctions, and Mortality in Critically Ill Surgical Patients: A Prospective, Stratified, Randomized, Double-Blind, Placebo-controlled Clinical Trial
Am. J. Respir. Crit. Care Med.,
October 15, 2002;
166(8):
1029 - 1037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chastre and J.-Y. Fagon
Ventilator-associated Pneumonia
Am. J. Respir. Crit. Care Med.,
April 1, 2002;
165(7):
867 - 903.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rello, J. A. Paiva, J. Baraibar, F. Barcenilla, M. Bodi, D. Castander, H. Correa, E. Diaz, J. Garnacho, M. Llorio, et al.
International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-Associated Pneumonia
Chest,
September 1, 2001;
120(3):
955 - 970.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. J. J. BERGMANS, M. J. M. BONTEN, C. A. GAILLARD, J. C. PALING, S. van der GEEST, F. H. van TIEL, A. J. BEYSENS, P. W. de LEEUW, and E. E. STOBBERINGH
Prevention of Ventilator-associated Pneumonia by Oral Decontamination . A Prospective, Randomized, Double-blind, Placebo-controlled Study
Am. J. Respir. Crit. Care Med.,
August 1, 2001;
164(3):
382 - 388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Members of the Task Force:, E. Bouza, C. Brun-Buisson, J. Chastre, S. Ewig, J-Y. Fagon, C.H. Marquette, P. Munoz, M.S. Niederman, L. Papazian, et al.
Ventilator-associated pneumonia: European Task Force on ventilator-associated pneumonia Chairmen of the Task Force: A. Torres and J. Carlet
Eur. Respir. J.,
May 1, 2001;
17(5):
1034 - 1045.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Kollef and V. J. Fraser
Antibiotic Resistance in the Intensive Care Unit
Ann Intern Med,
February 20, 2001;
134(4):
298 - 314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Lynch III
Hospital-Acquired Pneumonia : Risk Factors, Microbiology, and Treatment
Chest,
February 1, 2001;
119
(2009):
373S - 384S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. M. Bonten, B. J. Kullberg, R. van Dalen, A. R. J. Girbes, I. M. Hoepelman, W. Hustinx, J. W. M. van der Meer, P. Speelman, E. E. Stobberingh, H. A. Verbrugh, et al.
Selective digestive decontamination in patients in intensive care
J. Antimicrob. Chemother.,
September 1, 2000;
46(3):
351 - 362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Wunderink
Prevention of Ventilator-Associated Pneumonia : Does One Size Fit All?
Chest,
November 1, 1999;
116(5):
1155 - 1156.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. RELLO, E. DIAZ, M. ROQUE, and J. VALLÉS
Risk Factors for Developing Pneumonia within 48 Hours of Intubation
Am. J. Respir. Crit. Care Med.,
June 1, 1999;
159(6):
1742 - 1746.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J.-L. Vincent
Prevention of nosocomial bacterial pneumonia
Thorax,
June 1, 1999;
54(6):
544 - 549.
[Full Text]
|
 |
|

|
 |

|
 |
 
M. H. Kollef
The Prevention of Ventilator-Associated Pneumonia
N. Engl. J. Med.,
February 25, 1999;
340(8):
627 - 634.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. EWIG, A. TORRES, M. EL-EBIARY, N. FÁBREGAS, C. HERNÁNDEZ, J. GONZÁLEZ, J. M. NICOLÁS, and L. SOTO
Bacterial Colonization Patterns in Mechanically Ventilated Patients with Traumatic and Medical Head Injury . Incidence, Risk Factors, and Association with Ventilator-associated Pneumonia
Am. J. Respir. Crit. Care Med.,
January 1, 1999;
159(1):
188 - 198.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1997 American Thoracic Society
|
|
|